Effect of single-drug therapy on reduction of left atrial size in mild to moderate hypertension: Comparison of six antihypertensive agents

Circulation

Volumn 98, Issue 2, 1998, Pages 140-148

  Gottdiener, John S ^a,b   Reda, Domenic J ^a   Williams, David W ^a   Materson, Barry J ^a   Cushman, William ^a   Anderson, Robert J ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

Atrium; Drugs; Hypertension

Indexed keywords

ATENOLOL; CAPTOPRIL; CLONIDINE; DILTIAZEM; HYDROCHLOROTHIAZIDE; PRAZOSIN;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; DRUG EFFICACY; HEART ATRIUM FIBRILLATION; HEART ATRIUM HYPERTROPHY; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; STROKE; TREATMENT OUTCOME; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0032516451     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.2.140     Document Type: Article

References (23)

1. Dunn FG, Chandraratna P, Decarvalho JGR, Basta LL, Frohlich ED. Pathophysiologic assessment of hypertensive heart disease with echocardiography. Am J Cardiol. 1977;39:789-795.
2. Miller JT, O'Rourke RA, Crawford MH. Left atrial enlargement: an early sign of hypertensive disease. Am Heart J. 1988;116:1048-1051.
3. Pearson AC, Gudipati C, Nagelhout D, Sear J, Cohen JD, Labovirz AJ. Echocardiographic evaluation of cardiac structure and function in elderly subjects with isolated systolic hypertension. J Am Coll Cardiol. 1991;17: 422-430.
4. Gottdiener JS, Reda DJ, Williams DW, Materson BJ. Left atrial size in hypertensive men: influence of obesity, race, and age. J Am Coll Cardiol. 1997;29:651-658.
5. Henry W, Morganroth J, Pearlman Am Clark C, Redwood D, Itscoitz S, Epstein S. Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation. 1976;53:273-279.
6. Keren G, Etzion T, Sherez J, Zelcer A, Megidish R, Miller H, Laniado S. Atrial fibrillation and atrial enlargement in patients with mitral stenosis. Am Heart J. 1987;114:1146-1155.
7. The Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation, II: echocardiographic features of patients at risk. Ann Intern Med. 1992;116:6-12.
8. Gottdiener J, Reda D, Massie BM, Materson BJ, Williams DW, Anderson RJ. Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents: the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Circulation. 1997;95:2007-2014.
9. Vaziri S, Lauer M, Larson M, Benjamin E, Levy D. Influence of blood pressure on left atrial size. Hypertension. 1995;25:1155-1160.
10. Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS, Hamburger RJ, Fye C, Lakshman R, Gottdiener J. Single-drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo: the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents, N Engl J Med. 1993;328:914-921.
11. Sahn DJ, DeMaria A, Kisslo J, Weyman A. The committee on M-mode standardization of the American Society of Echocardiography: recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardioaraphic measurements. Circulation. 1978;58: 1072-1083.
12. Troy BL, Pombo J, Rackley CE. Measurement of left ventricular wall thickness and mass by echocardiography. Circulation. 1972;45:602-611.
13. Devereux RB. Detection of left ventricular hypertrophy by M-mode echocardiography: anatomic validation, standardization, and comparison to other methods. Hypertension. 1987;9(suppl II):II-19-II-26.
14. Diggle P, Liang K, Zeger S. Analysis of Longitudinal Data. Oxford, UK: Clarendon Press; 1994.
15. Little RJA. Modeling the drop-out mechanism in repeated-measures studies. J Am Stat Assoc. 1995;90:1112-1121.
16. SAS/STAT User's Guide, Version 6. 4th ed. Cary, NC: SAS Institute; 1989.
17. Qian XX, Chen AH, Deng JY, Tang XM, Liu YF, Li ZL, Ou SB, Wu ZN, Wang KR. The effect of Isoptin SR on blood pressure, heart function and hypertrophy of left ventricle of hypertensive patients. Chin Med J. 1994; 107:260-264.
18. 2+ blocker verapamil (Calan-SR) in hypertensive patients. J Cardiovasc Pharmacol. 1993;22: 637-643.
19. Kaul U, Mohan JC, Bhatia ML. Effects of labetalol on left ventricular mass and function in hypertension: an assessment by serial echocardiography. Int J Cardiol. 1984;5:461-473.
20. Pearson AC, Pasierski T, Labovitz AJ. Left ventricular hypertrophy: diagnosis, prognosis and management. Am Heart J. 1991;121:148-157.
21. Ghali JK, Liao Y, Simmons B, Castaner A, Cao G, Cooper RS. The prognostic role of left ventricular hypertrophy in patents with or without coronary artery disease. Ann Intern Med. 1992;117:831-836.
22. Benjamin EJ, D'Agostino RB, Belanger AJ, Wolf PA, Levy D. Left atrial size and the risk of stroke and death: the Framingham Heart Study. Circulation. 1995;92:835-841.
23. Gustafsson C, Britton M, Brolund F, Eriksson SV, Lindvall K. Echocardiographic findings and the increased risk of stroke in nonvalvular atrial fibrillation. Cardiology. 1992;81:189-195.